All Stories

  1. Commentary on: Does Surgeon Subjective Nerve Sparing Score Predict Recovery Time of Erectile Function Following Robot-Assisted Radical Prostatectomy?
  2. MP26-06 NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER
  3. MP30-02 A NOVEL DOSIMETER FOR MEASURING THE AMOUNT OF RADIATION EXPOSURE DURING PERCUTANEOUS NEPHROLITHOTOMY: INSTADOSE™
  4. MP33-08 PROGESTERONE SURGE DECREASES THE SEVERITY OF URETERAL STENT RELATED SYMPTOMS IN FEMALE PATIENTS
  5. 346 Delay of surgical treatment of penile fracture results in poor functional outcome: Results from a large retrospective multicenter European study
  6. MP18-19 DELAY OF SURGICAL TREATMENT OF PENILE FRACTURE RESULTS IN POOR FUNCTIONAL OUTCOME: RESULTS FROM A LARGE RETROSPECTIVE MULTICENTER EUROPEAN STUDY.
  7. PD36-07 TADALAFIL PREVENT PENILE NEURONAL NITRIC OXIDE SYNTHASE LEVELS WHICH DECREASE WITH CHRONIC PAROXETINE TREATMENT
  8. MP43-12 FACTORS CAUSING EJACULATION PROBLEMS: ANALYSES FROM THE TURKISH SOCIETY OF ANDROLOGY, MALE SEXUAL HEALTH STUDY GROUP
  9. PD48-12 RELATIONSHIP OF FACTORS ASSOCIATED WITH PEYRONIE'S DISEASE (PD) THAT AFFECT PD BOTHER AND ERECTILE DYSFUNCTION
  10. On-demand d-modafinil may be an effective treatment option for lifelong premature ejaculation: a case report
  11. Survey of the Literature for March 2015 Issue of Sexual Medicine Journal
  12. Men enjoy a year of significant progress
  13. S111: Factors affecting adherence to testosterone replacement therapy
  14. S112: Frequency of nocturnal emissions and its psychological consequences among sexually naïve religious teenagers
  15. What Can Be Done to Maintain Men's Health: Perspectives from the EAU Young Academic Urologists Working Party Men's Health Group
  16. Re: Associations Between Premature Ejaculation, Lower Urinary Tract Symptoms, and Erectile Dysfunction in Middle‐Aged Korean Policemen
  17. The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie’s disease
  18. Advances in treating premature ejaculation
  19. Effect of Botulinum‐A Toxin Injection into Bulbospongiosus Muscle on Ejaculation Latency in Male Rats
  20. An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation
  21. An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE)
  22. An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE)
  23. An Evidence‐Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation
  24. The Global Online Sexuality Survey (GOSS): The United States of America in 2011 ChapterIII—Premature Ejaculation Among English‐Speaking Male Internet Users
  25. Re: Peyronie's Disease Plaque Calcification—Prevalence, Time to Identification, and Development of a New Grading Classification
  26. Re: Baseline Characteristics from an Ongoing Phase 3 Study of Collagenase Clostridium Histolyticum in Patients with Peyronie's Disease
  27. Pharmaco-induced erections for penile color-Doppler ultrasound: oral pde5 inhibitors or intracavernosal injection?
  28. Gene mapping of serotoninergic system polymorphisms provides insight on pathology and treatment of men with lifelong premature ejaculation
  29. Erectile Function Outcomes after Robot‐Assisted Radical Prostatectomy: Is It Superior to Open Retropubic or Laparoscopic Approach?
  30. Chronic Escitalopram Treatment Induces Erectile Dysfunction by Decreasing Nitric Oxide Bioavailability Mediated by Increased Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity and Reactive Oxygen Species Production
  31. The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer
  32. Understanding the course of Peyronie's disease
  33. RE: The prevalence of premature ejaculation and its clinical characteristics in Korean men according to different definitions
  34. How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?
  35. Re: Long-Term Infection Outcomes of 3-Piece Antibiotic Impregnated Penile Prostheses Used in Replacement Implant Surgery
  36. 2043 SELENIUM AND LYCOPENE ATTENUATE CISPLATIN-INDUCED TESTICULAR TOXICITY ASSOCIATED WITH OXIDATIVE STRESS IN WISTER RATS
  37. Androgen Deprivation Therapy Impact on Quality of Life and Cardiovascular Health, Monitoring Therapeutic Replacement
  38. Adolescent varicocoele management controversies
  39. 4-Hydroxy-2,5,6-Triaminopyrimidine Enhances Expression of Mitochondrial Antioxidant Superoxide Dismutase in Human Corpora Cavernosa Cells
  40. Infection Retardant Coated Inflatable Penile Prostheses Decrease the Incidence of Infection: A Systematic Review and Meta-Analysis
  41. Re: Prevalence of ejaculatory disorders in urban men-results of a random-sample survey
  42. Alternate Therapies for Testosterone Replacement
  43. The Clinical Diagnosis of Androgen Deficiency
  44. New insights on premature ejaculation: a review of definition, classification, prevalence and treatment
  45. PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
  46. Epidemiology of Premature Ejaculation
  47. Risk Factors in Premature Ejaculation: The Urological Risk Factor
  48. Long‐Term Revision Rate due to Infection in Hydrophilic‐Coated Inflatable Penile Prostheses: 11‐Year Follow‐up
  49. A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction
  50. PENILE DOPPLER SONOGRAPHIC AND CLINICAL CHARACTERISTICS IN PEYRONIE'S DISEASE AND/OR ERECTILE DYSFUNCTION: AN ANALYSIS OF 1500 MEN WITH SEXUAL DYSFUNCTION
  51. Sexual Dysfunction Following Radical Prostatectomy
  52. Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation
  53. Premature Ejaculation and Erectile Dysfunction Prevalence and Attitudes in the Asia‐Pacific Region—A Comment
  54. Selenium and Lycopene Attenuate Cisplatin-induced Testicular Toxicity Associated With Oxidative Stress in Wistar Rats
  55. Re: Long-Term Infection Outcomes After Original Antibiotic Impregnated Inflatable Penile Prosthesis Implants: Up to 7.7 Years of Followup
  56. Re: Hartmut Porst, Edward D. Kim, Adolfo R. Casabé, et al., for the LVHJ study team. Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an Interna...
  57. Reply to Ege Can Serefoglu, Gregory C. Mitchell, and Wayne J.G. Hellstrom's Letter to the Editor re: Hartmut Porst, Edward D. Kim, Adolfo R. Casabé, et al., for the LVHJ study team. Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men Wi...
  58. An exploration of the association between male body mass index and semen quality
  59. 1380 LONG-TERM INFECTION OUTCOMES AFTER HYDROPHILIC COATED INFLATABLE PENILE PROSTHESIS IMPLANTS: 11 YEARS OF FOLLOW-UP
  60. 1697 THE DIRECTION AND SEVERITY OF PENILE CURVATURE DOES NOT HAVE AN IMPACT ON CONCOMITANT ERECTILE DYSFUNCTION IN PATIENTS WITH PEYRONIE'S DISEASE
  61. 213 ADIPOSE-DERIVED STEM CELL-SEEDED SMALL INTESTINAL SUBMUCOSA IN RAT PEYRONIE'S DISEASE MODEL FOR TUNICA ALBUGINEA GRAFTING AND RECONSTRUCTION
  62. 810 SILODOSIN (KMD-3213) IS A LONG-ACTING α-1A ADRENOCEPTOR ANTAGONIST WITH ACTIVITY IN THE HUMAN CORPUS CAVERNOSUM
  63. 1140 ASSESSMENT OF INTRAVAGINAL EJACULATORY TIME IN LIFELONG PREMATURE EJACULATION PATIENTS WITH AND WITHOUT MONOSYMPTOMATIC ENURESIS
  64. 1480 ONSET OF ACTION AND TIME TO EFFICACY OF AVANAFIL, A NOVEL, RAPID-ONSET PDE5 INHIBITOR IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION DATA FROM PHASE 2 AND PHASE 3 CLINICAL TRIALS
  65. Is sampling transitional zone in patients who had prior negative prostate biopsy necessary?
  66. How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?
  67. Urological risk factors for premature ejaculation
  68. The False Diagnosis of Venous Leak: Prevalence and Predictors—A Comment
  69. Anterior urethral diverticulum with multiple stones presenting as scrotal mass
  70. Treatment of Peyronie’s Disease: 2012 Update
  71. Escitalopram treatment for premature ejaculation has a negative effect on semen parameters
  72. The Comparison of Premature Ejaculation Assessment Questionnaires and Their Sensitivity for the Four Premature Ejaculation Syndromes: Results from the Turkish Society of Andrology Sexual Health Survey
  73. Prevalence of the Complaint of Ejaculating Prematurely and the Four Premature Ejaculation Syndromes: Results from the Turkish Society of Andrology Sexual Health Survey
  74. Computer Assisted Semen Analysis
  75. Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
  76. T-786C Polymorphism in Promoter of eNOS Gene as Genetic Risk Factor in Patients With Erectile Dysfunction in Turkish Population
  77. 67 HOW RELIABLE IS 12-CORE PROSTATE BIOPSY PROCEDURE IN THE DETECTION OF PROSTATE CANCER?
  78. 110 TISSUE SAMPLING IS NOT ADEQUATE IN THE DETECTION OF PROSTATE CANCER IN TRANSITION ZONE
  79. The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography
  80. The Distribution of Patients Who Seek Treatment for the Complaint of Ejaculating Prematurely According to the Four Premature Ejaculation Syndromes
  81. Botulinum toxin-A injection may be beneficial in the treatment of life-long premature ejaculation
  82. Re: Does Previous Extracorporeal Shock Wave Lithotripsy Affect the Performance and Outcome of Percutaneous Nephrolithotomy?
  83. Re: Renal Apoptosis Following Carbon Dioxide Pneumoperitoneum in a Rat Model
  84. Re: Outcomes Following Partial Nephrectomy by Tumor Size
  85. Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases
  86. Re: High Anterior Release of the Levator Fascia Improves Sexual Function Following Open Radical Retropubic Prostatectomy
  87. Ossification of renal cell carcinoma: a favorable marker
  88. 432 ANTIMICROBIAL ACTIVITY EVALUATIONS OF FOUR DIFERENT TYPES OF URETHRAL CATHETERS
  89. Factors affecting urethral stricture development after radical retropubic prostatectomy
  90. The Incidence and Management of Pleural Injuries Occurring during Open Nephrectomy
  91. Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejaculatory latency time
  92. Penile blood cyclic guanosin monophosphate level is associated with penile Doppler ultrasound findings
  93. Re: The 20-Core Prostate Biopsy Protocol—A New Gold Standard?
  94. Clinicopathological features and survival rates of patients with renal cell carcinoma under 50 years of age
  95. On the selection of rod-type eutectic morphologies: Geometrical constraint and array orientation
  96. Re: Effect of Saw Palmetto Soft Gel Capsule on Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Randomized Trial in Shanghai, China
  97. Re: Relationship Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Results From the Boston Area Community Health Survey
  98. Uroflowmetric assessment of acute effects of sildenafil on the voiding of men with erectile dysfunction and symptomatic benign prostatic hyperplasia
  99. Problems in Understanding the Turkish Translation of the International Index of Erectile Function
  100. Effects of transanal pelvic plexus stimulation on penile erection: clinical implications
  101. Retroperitoneal textiloma mimicking a renal tumor: Case Report